Otto Bock HealthCare, Duderstadt, Germany, (aka Ottobock) has formed a European supervisory board, as the med-tech company continues its process of converting to an SE & Co. KGaA, a type of limited partnership, by the end of 2017. The supervisory body is made up of six shareholder representatives and four members representing Ottobock’s employees from Germany, Austria, France, and Sweden. The supervisory board has elected Bernd Bohr, PhD, as chairman, and Joachim Kreuzburg, PhD, as deputy chairman.
“With the establishment of the supervisory body, the longstanding international focus of our company’s activities is now also reflected by the European supervisory board, and will soon be reflected in its legal status as well,” said Prof. Hans Georg Näder, president of Otto Bock Holding GmbH and Otto Bock HealthCare GmbH.
Shareholder representatives are Bohr, Kreuzburg, Marcus Brennecke, Prof. Gesche Joost, Georgia Näder, and Prof. Christoph H. Seibt. Employee representatives are Anja Rupprecht, Marcus Eder, Jean-Yves Audran, and Rose-Marie Kammarinen.
